To study correlation of molecular characteristics and clinical outcomes to crizotinib in ALK-positive patients
Latest Information Update: 17 Oct 2019
At a glance
- Drugs Crizotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 17 Oct 2019 New trial record
- 10 Sep 2019 Results presented at the 20th World Conference on Lung Cancer